Juvenile Diabetes Cure Alliance

Last updated
Juvenile Diabetes Cure Alliance (JDCA)
Type 501(c)(3) Nonprofit Organization
Foundedin 2010 in New York City, New York, U.S.
Founder
  • Brian Kelly
Area served
North America
Website thejdca.org

The Juvenile Diabetes Cure Alliance (JDCA) is a registered 501(c)(3) non-profit organization dedicated to developing a "Practical Cure" for type 1 diabetes. The organization advocates for increasing type 1 diabetes cure research and publishes reports on a variety of related topics, including research progress, fundraising utilization, and donor priorities. Established in 2010, the organization’s home office is in New York City and it focuses primarily on activity within the United States.

Contents

Activities include research, publishing, and advocating for T1D donors. All activities serve the nonprofit's ultimate purpose of bringing about what the organization calls a "Practical Cure" for type 1 diabetes. [1]

The organization defines a Practical Cure as any solution that gives people living with the disease the chance to live a normal, unrestricted life. The clinical requirements of a Practical Cure are defined by those living with T1D who understand the daily burden. Practical Cure requirements include testing blood sugars once a week or less, eating an unrestricted diet, a greatly reduced and simple regimen of medication, sleeping worry-free, experiencing minimal to no diabetes side effects, and experiencing fast recovery from surgeries. [2]

History

The JDCA was founded in 2010 by Brian Kelly, Chairman of the Board of Activision Blizzard, after his son was diagnosed with type 1 diabetes at the age of two. Kelly founded the organization to accelerate a cure for type 1 within his son’s lifetime.

At the time of its founding, the JDCA adopted a business, results-focused perspective in an effort to hold major diabetes fundraising nonprofit organizations accountable for the absence of measurable progress tracking and a lack of transparency to the donor public. [3] One key theme maintained as the organization has evolved is that donor priorities and the utilization of funds by major fundraisers should be aligned. [4]

As of 2022, the JDCA has published over 300 reports on topics related to finding a cure for Type 1 Diabetes. These reports include updates to existing human clinical trials with the potential to become Practical Cures, financial analysis of the top non-profit organizations, breaking news in T1D research, and others.

practical cure definition Pc def.jpg
practical cure definition

Research and publishing

Between 20 and 40 reports are published per year on the Juvenile Diabetes Cure Alliance Website and sent via email to an audience that is currently a little over 200,000 people. There are four main types of reports: Human Trials Research, State of the Cure, Utilization of Funds, and Donor Sentiment.

Human trials research progress

The JDCA tracks and categorizes type 1 diabetes potential Practical Cure research projects that are in human trials or about to start human trials. The list of projects is updated twice a year. While most projects have remained constant, some have been removed over time for insufficient test results and new ones have been added. [5]

State of the Cure


"State of the Cure for Type 1 Diabetes" provides an annual overview of progress toward a T1D cure throughout the year. [6] The State of the Cure reflects on the challenges, advancements, and steps needed to move forward with finding a Practical Cure.


Utilization of funds

The organization evaluates and analyzes the income and expenses of diabetes charities and publishes reports on how funds are utilized. [7]

For example, although both the JDRF and ADA raised about $200 million in 2019, only 37 cents of each dollar raised by the JDRF was attributed to research and the ADA spent less than 10 cents of every dollar on T1D research. [8]

The organization also believes that executive pay at non-profits like the JDRF and ADA should be primarily incentive-based; tied to both organizational advancements and tangible progress toward a T1D cure and treatment. [8] The JDCA also advocates for a donor Say on Pay model, in which donors would have a say in executive compensation, promoting accountability to non-profit employees.

At the highest-performing for-profit companies, top executives’ annual compensation is often directly correlated to performance. The better the company does, the more executives are rewarded. This form of incentive creates a powerful professional and personal zeal to drive the company toward palpable results that benefit stakeholders and shareholders alike. Unfortunately, this business model does not usually carry over to nonprofit organizations. The JDCA believes this is a missed opportunity to drive passion, accentuate focus, and improve overall performance toward achieving organizational goals.

Donor sentiment

Based on survey results, the JDCA publishes multiple annual reports that detail the sentiments of the T1D community, specifically regarding priorities and values. A consistent finding is that the number one priority of the T1D donor community is developing a cure for type 1 diabetes. According to annual community surveys, 97% of T1D donors say that the number one reason they donate is to fund cure research. [8]

Advocating for an increase in type 1 diabetes research

The JDCA advocates for a significant increase in spending on cure research for type 1 diabetes through annual petitions. [9] Its activities have fostered some discussion within the diabetes community. [10] The 2023 9th Annual More for a T1D Cure petition to increase cure funding acquired 388,000 signatures. [11]


The JDCA also provides services for donors who want to legally stipulate how their gifts will be used. [12] [13]

Criticism

The JDCA’s approach has been controversial for its focus on outcomes and expediency rather than traditional methods of deciding what projects to fund. [14]

Critics of the JDCA have stated that the definition of a cure can vary depending on who you ask. Others argue that a cure by 2035 is unobtainable and that improved diabetes treatments are a more valid outlet for funding than the JDCA acknowledges. [15]

Related Research Articles

A nonprofit organization (NPO) or non-profit organization, also known as a non-business entity, or nonprofit institution, is a legal entity organized and operated for a collective, public or social benefit, in contrary with an entity that operates as a business aiming to generate a profit for its owners. A nonprofit is subject to the non-distribution constraint: any revenues that exceed expenses must be committed to the organization's purpose, not taken by private parties. An array of organizations are nonprofit, including some political organizations, schools, business associations, churches, social clubs, and consumer cooperatives. Nonprofit entities may seek approval from governments to be tax-exempt, and some may also qualify to receive tax-deductible contributions, but an entity may incorporate as a nonprofit entity without securing tax-exempt status.

<span class="mw-page-title-main">Fundraising</span> Process of gathering donations

Fundraising or fund-raising is the process of seeking and gathering voluntary financial contributions by engaging individuals, businesses, charitable foundations, or governmental agencies. Although fundraising typically refers to efforts to gather money for non-profit organizations, it is sometimes used to refer to the identification and solicitation of investors or other sources of capital for for-profit enterprises.

<span class="mw-page-title-main">Leukemia & Lymphoma Society</span> North American blood cancer charitable organization

The Leukemia & Lymphoma Society (LLS), a 501(c)(3) charitable organization founded in 1949, is a voluntary health organization dedicated to fighting blood cancer world-wide. The LLS mission is: Cure leukemia, lymphoma, Hodgkin's disease, and myeloma, and improve the quality of life of patients and their families. LLS funds blood cancer research around the world, provides free information and support services, and is a voice for all blood cancer patients seeking access to quality and affordable care.

JDRF is a nonprofit 501(c)(3) organization that funds type 1 diabetes (T1D) research, provides a broad array of community and activist services to the T1D population and actively advocates for regulation favorable to medical research and approval of new and improved treatment modalities. It was initially founded as the JDF, the Juvenile Diabetes Foundation. It later changed its name to the Juvenile Diabetes Research Foundation and is now known as JDRF.

The American Diabetes Association (ADA) is a United States-based nonprofit that seeks to educate the public about diabetes and to help those affected by it through funding research to manage, cure and prevent diabetes. It is a network of 565,000 volunteers which includes 20,000 healthcare professionals and administration staff members.

<span class="mw-page-title-main">2004 California Proposition 71</span> California law

Proposition 71 of 2004 is a law enacted by California voters to support stem cell research in the state. It was proposed by means of the initiative process and approved in the 2004 state elections on November 2. The Act amended both the Constitution of California and the Health and Safety Code.

The Alliance for Aging Research is a non-profit organization based in Washington, D.C., that promotes medical research to improve the human experience of aging. Founded in 1986 by Daniel Perry, the Alliance also advocates and implements health education for consumers and health professionals.

Automated insulin delivery systems are automated systems designed to assist people with insulin-requiring diabetes, by automatically adjusting insulin delivery in response to blood glucose levels. Currently available systems can only deliver a single hormone—insulin. Other systems currently in development aim to improve on current systems by adding one or more additional hormones that can be delivered as needed, providing something closer to the endocrine functionality of the pancreas.

The Environmental Determinants of Diabetes in the Young is a longitudinal study examining the environmental causes of Type 1 diabetes (T1D), formerly known as juvenile diabetes. The study follows children at high genetic risk for T1D from birth to 15 years of age.

<span class="mw-page-title-main">Arthritis Foundation</span> American nonprofit organization

The Arthritis Foundation is a nonprofit organization addressing the needs of people living with arthritis in the United States.

<span class="mw-page-title-main">Children at Risk</span> U.S. non-profit organization

Children At Risk is a 501(c)(3) non-profit organization that drives changes for children through research, education, and influencing public policy. Founded in the year of 1989 in Houston, Texas and with an office opened in North Texas in 2011, the organization focuses on the well-being of children and educates legislators on the importance of solving children's issues while at the same time focusing on a variety of issues, and the primary issues are human trafficking, food insecurity, education, and parenting. Children At Risk also has a North Texas office in Dallas, Texas. Some of Children At Risk's previous primary issues were juvenile justice, mental health, and Latino children.

Candid is an information service specializing in reporting on U.S. nonprofit companies. In 2016, its database provided information on 2.5 million organizations. It is the product of the February 2019 merger of GuideStar with Foundation Center.

The Commission on Private Philanthropy and Public Needs, better known as the Filer Commission, was formed in 1973 to study philanthropy, the role of the private sector in American society, and then to recommend measures to increase voluntary giving. Organized as a privately supported citizen's board, the Commission came into being through the efforts of John D. Rockefeller III, Wilbur D. Mills, George P. Shultz, and William E. Simon. The selection of participants on the Commission reflected a desire for diversity of experience and opinions and included heads of religious and labor groups, former cabinet secretaries, corporate and fd Foreign Securities Corporation and President of Metropolitan Museum of Art.

  1. Edwin D. Etherington, Former President of Wesleyan University and Trustee of Alfred P. Sloan Foundation.
  2. Bayard Ewing, Tillinghast, Collins and Graham and Vice Chairman of United Way of America.
  3. Frances Tarlton Farenthold, Past Chairperson of National Women's Political Caucus.
  4. Max M. Fisher, Chairman of United Brands Company and Honorary Chairman of United Foundations.
  5. Reverend Raymond J. Gallagher, Bishop of Lafayette-in-Indiana.
  6. Earl G. Graves, Publisher of Black Enterprise and Commissioner of Boy Scouts of America.
  7. Paul R. Haas, President and Chairman of Corpus Christi Oil and Gas Company and Trustee of Paul and Mary Haas Foundation.
  8. Walter A. Haas Jr., Chairman of Levi Strauss and Company and Trustee of the Ford Foundation.
  9. Philip M. Klutznick, Klutznick Investments and Chairman of Research and Policy Committee and Trustee of Committee for Economic Development.
  10. Ralph Lazarus, Chairman of Federated Department Stores, Inc. and Former National Chairman of United Way of America.
  11. Herbert E. Longenecker, President Emeritus of Tulane University and Director of United Student Aid Funds.
  12. Elizabeth J. McCormack, Special Assistant to the President of Rockefeller Brothers Fund, Inc.
  13. Walter J. McNerney, President of Blue Cross Association.
  14. William H. Morton, Trustee of Dartmouth College.
  15. John M. Musser, President and Director of General Service Foundation.
  16. Jon O. Newman, Judge, U.S. District Court and Chairman of Hartford Institute of Criminal and Social Justice.
  17. Graciela Olivarez, State Planning Officer and Director of Council on Foundations, Inc.
  18. Alan Pifer, President of Carnegie Corporation of New York.
  19. George Romney, Chairman of the National Center for Voluntary Action.
  20. William Matson Roth, Regent of University of California and Chairman of San Francisco Museum of Art.
  21. Althea T. L. Simmons, Director for Education Programs of the NAACP Special Contribution Fund.
  22. Reverend Leon H. Sullivan, Pastor of Zion Baptist Church, Philadelphia.
  23. David B. Truman, President of Mount Holyoke College.

The National Health Council (NHC) is a nonprofit association of health organizations.

<span class="mw-page-title-main">Mark Atkinson (scientist)</span> American medical researcher (born 1961)

Mark Atkinson is an American medical researcher best known for his contributions to research seeking to predict, prevent, and cure type 1 diabetes. He is the author of over 600 publications and is one of the world's most cited diabetes researchers.

The Reagan-Udall Foundation for the Food and Drug Administration is a private nonprofit (501c3) organization, created to support the mission of the U.S. Food and Drug Administration (FDA) to help equip FDA staff with the highest caliber, regulatory science and technology in order to enhance the safety and effectiveness of FDA regulated products. Although it was mandated by Congress in the Food and Drug Administration Amendments Act of 2007 to help support and promote FDA's regulatory science priorities, it is independent of the agency, with its own Board of Directors, staff and research agenda. The Reagan-Udall Foundation creates public–private partnerships to advance research in regulatory science, enhance medical decision making, and promote innovation. It also advances regulatory science through fellowships and other training programs, both for private scientists and for FDA staff.

<span class="mw-page-title-main">Susan Alberti</span> Australian businesswoman (born 1947)

Susan Marie "Sue" Alberti is an Australian businesswoman, philanthropist and former Vice President of the Western Bulldogs Football Club.

<span class="mw-page-title-main">Benaroya Research Institute</span>

Benaroya Research Institute (BRI) is a Seattle, Washington non-profit organization that conducts medical research on many diseases and immune disorders, including autoimmune disease. It is affiliated with Virginia Mason Health System, and is located on the campus of Virginia Mason Medical Center.

<span class="mw-page-title-main">Delta Epsilon Psi</span> American South Asian-interest collegiate fraternity

Delta Epsilon Psi (ΔΕΨ) is a South Asian interest social and service fraternity located in the United States. Delta Epsilon Psi Fraternity, Inc. was founded on October 1, 1998 at the University of Texas at Austin. The 18 founders formed the fraternity to provide a unified South Asian voice at the school.

Charity assessment is the process of analysis of the goodness of a non-profit organization in financial terms. Historically, charity evaluators have focused on the question of how much of contributed funds are used for the purpose(s) claimed by the charity, while more recently some evaluators have placed an emphasis on the cost effectiveness of charities.

References

  1. ↑ Connect, Diabetic. "Finding a "Practical Cure" for Diabetes". diabeticconnect.
  2. ↑ O’Meara, Alex (July 2, 2013). "A Sweet Life".
  3. ↑ Donovan, Doug (September 22, 2013). "Nonprofit Leader Pushes Idea of Tying Executive Pay to Progress in Accomplishing Mission. The Chronicle of Philanthropy".
  4. ↑ Grayce West, Melanie (June 12, 2013). "Aligning Donors To Fight Diabetes". The Wall Street Journal.
  5. ↑ Connect, Diabetic (August 31, 2015). "Orgenesis Included in Juvenile Diabetes Cure Alliance 2015 Update of Emerging Practical Cure Projects". Yahoo Finance.
  6. ↑ "STATE OF THE CURE". thejdca. November 2022.
  7. ↑ Parkinson, John (April 13, 2012). "Follow the Donations: Accounting for the Monies Given to the Largest Research Foundations". diabetescare.
  8. 1 2 3 "Many Problems with Diabetes Cure Research, Says JDCA". 22 March 2018.
  9. ↑ Health, Diabetes (September 7, 2016). "Type 1 Diabetes Community Fights for a Major Increase in Cure Research. NBC News".
  10. ↑ Bacon, Katie (October 6, 2015). "Should JDRF and ADA Fund More Diabetes Cure Research?".
  11. ↑ Woodfield, Jack (September 6, 2018). "Juvenile Diabetes Cure Alliance petition demands an increase in T1D Cure Research Funding".
  12. ↑ Demasters, Karen (January 16, 2014). "How To Make The Most Of Philanthropy".
  13. ↑ "Stipulation Card".
  14. ↑ Pogorelc, Deanna (October 22, 2013). "Research analysis finds "little tangible progress toward a cure" for type 1 diabetes".
  15. ↑ Strange, Scott (November 11, 2011). "Hello JDCA, I'm Part Of The 85".
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.